Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2016 - 2025)

Rocket Pharmaceuticals' Interest Coverage Ratio history spans 9 years, with the latest figure at 92.95 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 29.88% year-over-year to 92.95; the TTM value through Dec 2025 reached 122.55, up 15.4%, while the annual FY2025 figure was 122.55, 15.4% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 92.95 at Rocket Pharmaceuticals, up from 110.46 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 22.68 in Q1 2021 and bottomed at 156.5 in Q2 2024.
  • The 5-year median for Interest Coverage Ratio is 133.76 (2023), against an average of 122.64.
  • The largest annual shift saw Interest Coverage Ratio crashed 928.35% in 2021 before it rose 29.88% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 95.75 in 2021, then crashed by 54.49% to 147.93 in 2022, then grew by 8.98% to 134.64 in 2023, then increased by 1.55% to 132.55 in 2024, then grew by 29.88% to 92.95 in 2025.
  • Per Business Quant, the three most recent readings for RCKT's Interest Coverage Ratio are 92.95 (Q4 2025), 110.46 (Q3 2025), and 150.42 (Q2 2025).